Healthcare provider profile · identity verified

George Walker Jackson, MD

Family Practice · EL PASO, TX · NPI 1962406694

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	668	202
Lisinopril	Lisinopril	530	163
Levothyroxine Sodium	Levothyroxine Sodium	494	135
Metformin Hcl	Metformin Hcl	489	155
Losartan Potassium	Losartan Potassium	379	106
Amlodipine Besylate	Amlodipine Besylate	354	116
Simvastatin	Simvastatin	304	94
Rosuvastatin Calcium	Rosuvastatin Calcium	250	88
Gabapentin	Gabapentin	225	61
Metoprolol Succinate	Metoprolol Succinate	221	58
Hydrochlorothiazide	Hydrochlorothiazide	206	56
Tamsulosin Hcl	Tamsulosin Hcl	172	63
Omeprazole	Omeprazole	171	59
Montelukast Sodium	Montelukast Sodium	142	41
Alendronate Sodium	Alendronate Sodium	128	49
Pioglitazone Hcl	Pioglitazone Hcl	128	37
Albuterol Sulfate Hfa	Albuterol Sulfate	125	53
Finasteride	Finasteride	117	39
Trazodone Hcl	Trazodone Hcl	115	29
Alprazolam	Alprazolam	110	37
Pantoprazole Sodium	Pantoprazole Sodium	108	37
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	107	31
Carvedilol	Carvedilol	103	34
Furosemide	Furosemide	103	41
Tramadol Hcl	Tramadol Hcl	98	41
Pravastatin Sodium	Pravastatin Sodium	96	35
Donepezil Hcl	Donepezil Hcl	95	32
Januvia	Sitagliptin Phosphate	94	22
Glipizide	Glipizide	92	29
Metoprolol Tartrate	Metoprolol Tartrate	91	36
Clonazepam	Clonazepam	90	17
Sertraline Hcl	Sertraline Hcl	88	30
Eliquis	Apixaban	85	27
Clopidogrel	Clopidogrel Bisulfate	84	31
Lovastatin	Lovastatin	80	23
Famotidine	Famotidine	77	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	77	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	19
Fluticasone Propionate	Fluticasone Propionate	63	32
Vitamin D2	Ergocalciferol (Vitamin D2)	59	16
Allopurinol	Allopurinol	56	20
Memantine Hcl	Memantine Hcl	54	20
Pregabalin	Pregabalin	54	12
Potassium Chloride	Potassium Chloride	53	17
Jardiance	Empagliflozin	52	21
Tizanidine Hcl	Tizanidine Hcl	52	14
Buspirone Hcl	Buspirone Hcl	50	suppressed
Duloxetine Hcl	Duloxetine Hcl	49	14
Hydralazine Hcl	Hydralazine Hcl	46	14
Escitalopram Oxalate	Escitalopram Oxalate	44	17
Meloxicam	Meloxicam	44	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	15
Mirtazapine	Mirtazapine	41	11
Quetiapine Fumarate	Quetiapine Fumarate	41	suppressed
Spironolactone	Spironolactone	41	16
Acetaminophen-Codeine	Acetaminophen With Codeine	39	suppressed
Glimepiride	Glimepiride	38	13
Benazepril Hcl	Benazepril Hcl	31	suppressed
Terazosin Hcl	Terazosin Hcl	31	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	29	12
Farxiga	Dapagliflozin Propanediol	29	suppressed
Ozempic	Semaglutide	29	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Prednisone	Prednisone	28	suppressed
Nifedipine Er	Nifedipine	27	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	26	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	suppressed
Ibuprofen	Ibuprofen	24	11
Trulicity	Dulaglutide	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Fenofibrate	Fenofibrate	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Sildenafil Citrate	Sildenafil Citrate	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	11
Glipizide Er	Glipizide	20	suppressed
Lactulose	Lactulose	20	suppressed
Temazepam	Temazepam	19	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Atenolol	Atenolol	16	suppressed
Cephalexin	Cephalexin	16	15
Estradiol	Estradiol	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	16
Combivent Respimat	Ipratropium/Albuterol Sulfate	15	suppressed
Valsartan	Valsartan	15	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Naproxen	Naproxen	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Baclofen	Baclofen	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Nitroglycerin	Nitroglycerin	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error